|
|||||
|
|
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways |
|
| Authors: | Yozo Mitsui Hiroshi Hirata Naoko Arichi Miho Hiraki Hiroaki Yasumoto Inik Chang Shinichiro Fukuhara Soichiro Yamamura Varahram Shahryari Guoren Deng Sharanjot Saini Shahana Majid Rajvir Dahiya Yuichiro Tanaka Hiroaki Shiina |
| Institution: | 1. Department of Urology, Shimane University Faculty of Medicine, Enya-cho, Izumo, Japan;2. Department of Urology, San Francisco Veterans Affairs Medical Center and University of California San Francisco, San Francisco, California, USA;3. Department of Oral Biology, Yonsei University College of Densitry, Seoul, South Korea;4. Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan |
| Abstract: | |
| Keywords: | bone morphogenetic protein 2 renal cell carcinoma DNA methylation molecular marker |